Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is -7.40% vs 18.04% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -0.84% vs 4.68% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is -2.18% vs 4.28% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 3.45% vs -12.12% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Nanjing Well Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is -7.40% vs 18.04% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -9.66% vs 29.67% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -0.84% vs 4.68% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -19.68% vs 68.06% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -2.18% vs 4.28% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 12.22% vs 49.23% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 3.45% vs -12.12% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -31.82% vs 4.76% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






